Rajeev Tyagi | Immunology | Best Researcher Award

Dr. Rajeev Tyagi | Immunology | Best Researcher Award

CSIR-Institute of Microbial Technology (IMTECH), India

Author Profile

Early Academic Pursuits:

Rajeev K. Tyagi, Ph.D., began his academic journey with a Bachelor's degree in Biology followed by a Master's degree in Biotechnology from C.C.S University, Meerut, UP, India. He then pursued his Ph.D. in Immunology, Parasitology, and Vaccinology from the prestigious Institute Pasteur in Paris, France, focusing on humanized mouse models for malaria research.

Professional Endeavors:

His professional career spans over 17 years, encompassing various roles in academia, research, and scientific leadership. He has served as an Assistant Professor at Amity Institute of Microbial Technology and Institute of Science, Nirma University, India. Additionally, he held the position of Scientist at the Biosafety Support Unit, Department of Biotechnology, New Delhi, India.

Contributions and Research Focus:

His research interests lie in humanized mouse models, vaccine development, diagnostics, and nano-drug delivery systems in translational biomedical research. He has contributed significantly to understanding host-parasite interactions in malaria, leading to innovative approaches for disease control and treatment. His work spans across national and international collaborations, focusing on cutting-edge technologies and multidisciplinary approaches.

Accolades and Recognition:

Throughout his career, He has been recognized with numerous awards and honors for his outstanding contributions to the field of biomedical research. These include prestigious fellowships such as the Ramalingaswami Fellowship and awards for his research excellence in malaria and medical entomology. His doctoral thesis received high commendation for its quality and contribution to the field.

Impact and Influence:

His research has had a significant impact on advancing our understanding of infectious diseases, particularly malaria, and developing novel strategies for prevention and treatment. His leadership in organizing conferences and workshops has facilitated knowledge exchange and collaboration among researchers globally, further enhancing the impact of his work.

Legacy and Future Contributions:

As a leader in biomedical research, His legacy lies in his dedication to scientific excellence, innovation, and mentorship. He continues to lead cutting-edge research projects and mentor the next generation of scientists, aiming to address global health challenges and improve human health outcomes. His future contributions are poised to further advance our knowledge and capabilities in combating infectious diseases and improving public health worldwide.

Citations

A total of  2239 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations            2239
  • h-index              28
  • i10-index           44

Notable Publications 

Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment

Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin

Surface engineered polymeric nanocarriers mediate the delivery of transferrin-methotrexate conjugates for an improved understanding of brain cancer.

Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder (s)

Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis

Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1

Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics

Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model

Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic …

A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne

 

 

Song Guo Zheng | Autoimmunity Disease and Inflammation | Outstanding Scientist Award

Prof Dr. Song Guo Zheng | Autoimmunity Disease and Inflammation | Outstanding Scientist Award🏆

Professional Profile

Early Academic Pursuits

Song Guo Zheng embarked on his academic journey with an MD from Anhui Medical University followed by an MS from Fudan University Shanghai School of Medicine and eventually earned his PhD from the University of Orleans in France. These foundational educational pursuits laid the groundwork for his distinguished career.

Professional Endeavors

His professional journey spans over four decades, showcasing a progressive trajectory marked by pivotal roles at esteemed institutions globally. Noteworthy positions include his tenure as the Ronald L. Whisler Chair in Rheumatology and Immunology at the Ohio State University School of Medicine, along with significant roles at the Pennsylvania State University Hershey Medical Center and the University of Southern California Keck School of Medicine.

Contributions and Research Focus

As a pioneer in immunology, Dr. Zheng's contributions are profound. Notably, his discovery of induced regulatory T cells and extensive work on Gingival Mesenchymal Stem Cells in autoimmune diseases have reshaped the landscape of immunotherapy. His studies on immune regulatory T cells, mechanisms of induction, and identification of various subsets have significantly influenced the understanding and treatment of autoimmune conditions.

Accolades and Recognition

His exceptional contributions have garnered widespread acclaim, evident through numerous prestigious awards such as the Freda Newton Memorial Scholar Award, ACR Investigator Award, NIH Star Award, and more. His impressive publication record, with an H-index of 74 and over 210 publications, solidifies his standing as a leading expert in rheumatology, immunology, allergy, and inflammatory diseases.

Impact and Influence

His impact resonates through his pivotal discoveries in immune regulation and innovative approaches in treating inflammatory diseases. His findings on Treg cell therapy, retinoic acid's role in Treg amplification, and identifying novel targets for inhibiting inflammatory diseases showcase his far-reaching influence on the field.

Legacy and Future Contributions

His legacy stands as a testament to groundbreaking research, innovative treatments, and a commitment to advancing autoimmune disease therapeutics. His future contributions are anticipated to further revolutionize immunotherapy, leveraging novel findings and continued dedication to unraveling the complexities of immune regulation and inflammatory diseases.

Notable Publications 

Natural and induced CD4+ CD25+ cells educate CD4+ CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10
SG Zheng, JH Wang, JD Gray, H Soucier, DA Horwitz
( 920 )2004

IL-2 is essential for TGF-β to convert naive CD4+ CD25− cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells

SG Zheng, J Wang, P Wang, JD Gray, DA Horwitz
( 775 )2007

Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors
SG Zheng, JD Gray, K Ohtsuka, S Yamagiwa, DA Horwitz
( 588 )2002

Role of vitamin A in the immune system
Z Huang, Y Liu, G Qi, D Brand, SG Zheng
( 571 )2018

TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells

SG Zheng, JH Wang, W Stohl, KS Kim, JD Gray, DA Horwitz
( 472 )2006

Natural and TGF-β–induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other
DA Horwitz, SG Zheng, JD Gray

Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications
S Yang, J Wang, DD Brand, SG Zheng
( 324 )2018

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3
Z Chen, J Barbi, S Bu, HY Yang, Z Li, Y Gao, D Jinasena, J Fu, F Lin, ...
( 308 )2013

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets
DA Horwitz, SG Zheng, JD Gray
( 303 )2003

CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome
SG Zheng, JH Wang, MN Koss, F Quismorio, JD Gray, DA Horwitz
( 285 )2004

Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms
Y Luo, SG Zheng
( 282 )2016

Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu
X Zhou, N Kong, J Wang, H Fan, H Zou, D Horwitz, D Brand, Z Liu, ...
( 260 )2010

Citations

A total of  1646 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations          17730       10684
  • h-index             75              58
  • i10-index          187           177